Business

January 13, 2014 5:16 PM

Salix shares hit 52-week high

Shares of Salix Pharmaceuticals rose to a 52-week high Monday after the company announced upbeat projections in the wake of its recent acquisition of specialty drug company Santarus.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs